FDA Announces Draft Guidance for Industry on Formal Meetings with Sponsors of Prescription Drug Products

Summary

The FDA is releasing a draft guidance document outlining recommendations for formal meetings between the agency and sponsors or applicants of prescription drug products under the Prescription Drug User Fee Act (PDUFA). The guidance revises a previous version published in 2009.